Highlights from ExL Pharma's 2nd European Clinical Data Disclosure Summit
FDAAA Title VIII ( PL 110-85, Section 801) Expanded Clinical Trials Registry and Results Database Status Report on Implementation Theresa Toigo Director,
May 20081 Expansion of Clinical Trial Registration and Results Reporting Requirements Deborah A. Zarin, M.D. ClinicalTrials.gov National Library of Medicine.
The criminal process 2
STAGES OF THE POLICY PROCESS. Problem Identification Policy Formation Policy Analysis Policy Choice Policy Legitimation Policy Implementation Policy Evaluation.
111 Update on Clinical Trials Registration and Results Reporting Requirements Deborah A. Zarin, M.D. ClinicalTrials.gov February 24, 2009.
500 100 200 300 100 300 200 300 200 100 200 500 300 100 400 Who’s Who in the Courtroom Judges & Lawyers Think Like a Lawyer Bill of Rights Trials 200.
Embrace the Hill Gain Reasons for Hardships: - You - Them - Life.
Chapter 3a The Science of Astronomy
111 Methodologic Issues and Next Steps in the Implementation of the Results Database Deborah A. Zarin, M.D. ClinicalTrials.gov February 24, 2009.
SPOREs Specialized Programs of Research Excellence Ryan Landy Qinyan Pan -SAIC 2003 NCICB Jamboree.
1 Session 2 Expanded Clinical Trials Registry Deborah A. Zarin, M.D. NLM Accomplishments Impact to Date Specific Data Element Issues.